Most pharma manufacturing AI roadmaps fund the exciting use case first and the highest-leverage one last. This guide gives you the right order, a ranked, sourced priority sequence across Quality and Plant Operations, with the deviation, downtime, and dollar impact behind each.
Eleven questions. Two functions. One sourced sequence.
30%
Average pharma plant OEE runs around 30%, against an aspirational 70%. Many sites could realistically double output.
Industry manufacturing OEE research · cited in the guideSeven guides, from the CEO agenda to the plant floor. Each is a ranked, sourced priority sequence, built on research from Bain, McKinsey, Deloitte, BCG, EY, ZS and MIT NANDA.
Eleven questions. Two functions. One sourced sequence. Free, no spam, no sales pitch first.
Backed by industry manufacturing OEE and process research
The guide is on its way to your inbox.